Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

New combination for contraception in males

Sep. 20, 1996

Another new use claimed for raloxifene

Sep. 20, 1996

Vivus seeks approval for impotence treatment

Sep. 20, 1996

Tulane U. investigates GHRH agonists

Sep. 20, 1996

New use for 5-HT2 antagonist

Sep. 20, 1996

Troglitazone nearing launch

Sep. 20, 1996

New indications discovered for Ligand's retinoid compound, Targretin

Sep. 20, 1996

Immunex issued first patent on blood stem cell factor

Sep. 20, 1996

New indication claimed for EPO

Sep. 20, 1996

NPY antagonists from Glaxo Wellcome

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...